Group CFO
Susan has recently joined as the Group CFO. She is an accomplished board-level executive with extensive experience across public and private companies, spanning multinational corporations, growth SMEs, and startups.
A proven leader in finance and strategy, she has successfully delivered business transformation, M&A integration, and shareholder value creation through multiple exits—including three trade sales and a public listing on AIM.
Over her career, she has raised more than £150 million through equity, venture debt, and structured financing.
Most recently, she served as CFO and Company Secretary of Arecor Therapeutics plc, playing a pivotal role in its oversubscribed AIM listing and strategic acquisitions.
She currently chairs the Audit & Risk Committee at BiVictrix Therapeutics and continues to bring deep expertise in governance, corporate growth, and stakeholder engagement.